DEA Considers Reclassifying Marijuana from Schedule I to III
Stricter Regulations for Dispensaries Anticipated
In a significant shift in American drug policy, the US Drug Enforcement Administration (DEA) is deliberating on reclassifying marijuana from Schedule I to Schedule III, recognizing its medical benefits and lower abuse potential. This move comes amidst growing support for decriminalization.
Schedule I is a category within the Drug Enforcement Administration's (DEA) drug scheduling system that classifies substances deemed to have a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. Substances under Schedule I are considered the most tightly controlled and are prohibited for use, possession, or distribution under federal law in the United States.
Schedule III is a category within the Drug Enforcement Administration's (DEA) drug scheduling system that classifies substances with a moderate to low potential for physical and psychological dependence. These substances have an accepted medical use in treatment and may lead to moderate or low physical dependence or high psychological dependence. Schedule III drugs are subject to regulation and control under federal law in the United States.
Critics of the proposed reclassification argue that marijuana could act as a “gateway drug,” while proponents advocate for regulating it akin to alcohol. Notably, the potential reclassification of marijuana coincides with stricter bans on cigarette smoking in various settings, reflecting evolving attitudes towards substance use. The new reclassification may negatively impact individuals who are allergic to marijuana smoke, highlighting the complex considerations surrounding cannabis consumption in public spaces.
If the reclassification to Schedule III is finalized, marijuana dispensaries may face heightened scrutiny and stringent regulations, potentially requiring them to register with the DEA and adhere to strict reporting standards.
As stakeholders await the DEA’s final decision on the reclassification, the implications of this potential shift loom large over the marijuana industry and broader drug policy landscape. The outcome of this decision could reshape the regulatory environment for dispensaries and pave the way for a new chapter in the treatment of marijuana under federal law.
I have very mixed feelings about this. As a disclaimer, I do partake in its use - it's just to relax, perhaps 2-3 times a month over the last year or so. Alcohol was always my "drug" of choice, but at 50 years old, I can no longer enjoy it without my nerves flaring up afterwards. I do not like the smell or taste of marijuana and I don't like the way people look when they're high. I've seen way too many younger people who use it so habitually that they seemingly can't get through life without it. I will never be able to wrap my head around that, guess I'll always be a lightweight lol.
So, would this actually make marijuana easier to get? I imagine a prescription would still be necessary in the states where its required. I realize this is on the federal level, but if the classification is a downgrade, why would dispensaries face heightened scrutiny and more stringent regulations than they already do?
I am confused.....if they want us dead then why are they worried about us consuming cannabis?